Enrofloxacin 150 mg
For the treatment of bacterial single or combined infections of the respiratory, alimentary or urinary tract, the skin or wounds, caused by Enrofloxacin-sensitive gram-negative and gram–positive bacteria: Escherichia coli, Pasteurella spp., Haemophilus spp. and Staphylococci.
Posology:Oral use.
1 tablet/30 kg b.w., 5 - 10 days.
Not applicable.
10, 20, 30, 50, 100 tablets
* The information in the data sheet may be different according to your country’s regulations. If you have any doubts regarding this product, do not hesitate on contacting us.